Business, energy, technology, markets and global industry news from Business News Today

Medical Devices & Diagnostics

PharmaDeviceNews Medical Devices & Diagnostics
IceCure Medical’s ChoICE post-market study is evaluating the ProSense cryoablation system as a minimally invasive treatment option for eligible older patients with low-risk, early-stage breast cancer. Representative image.
Medical Devices & Diagnostics

What will IceCure Medical’s ChoICE study reveal about ProSense breast cancer cryoablation?

IceCure Medical launches the ChoICE post-market study at West Cancer Center, testing ProSense adoption and five-year outcomes in breast cancer.

Read More
Dopl Technologies’ $6.3 million seed funding is set to advance the Traverse telerobotic ultrasound platform toward FDA clearance, as remote robotic imaging gains attention for expanding diagnostic access in underserved hospitals. Representative image.
Medical Devices & Diagnostics

Can Dopl Technologies turn a $6.3m seed round into the remote ultrasound network rural hospitals need?

Dopl Technologies raises $6.3 million to fund FDA work for Traverse telerobotic ultrasound, but clinical validation and adoption remain key.

Read More
Digital critical care monitoring in a modern hospital setting, reflecting FIZE Medical’s European and UK commercial expansion after CE marking and UKCA certification for the FIZE kUO automated urine output system. Representative image.
Medical Devices & Diagnostics

FIZE Medical receives CE marking and UKCA certification for FIZE kUO

FIZE Medical’s CE and UKCA milestones open Europe and Great Britain to FIZE kUO, shifting attention to ICU adoption and clinical evidence.

Read More
An ophthalmic surgeon performs a glaucoma procedure as Glaukos Corporation advances the PRESERFLO MicroShunt through its U.S. pivotal study following completion of patient enrollment. Representative image.
Medical Devices & Diagnostics

Glaukos has enrolled the PRESERFLO pivotal study, but the decisive U.S. evidence is still ahead

Glaukos completes PRESERFLO pivotal enrollment, shifting focus to 12-month data, FDA clearance and advanced glaucoma adoption.

Read More
Redox and Lapsi Health are integrating the Keikku clinical AI platform with electronic health record workflows to support connected documentation, clinical data access and digital auscultation. Representative image.
Medical Devices & Diagnostics

Can Redox fix the integration bottleneck standing between Keikku and hospital-scale AI adoption?

Redox and Lapsi Health are linking Keikku with EHR workflows, but adoption will depend on validation, governance and health-system execution.

Read More
KMM Group targets next growth phase with RS2 Healthcare Partners capital and new CEO
Medical Devices & Diagnostics

Why RS2 Healthcare Partners is backing KMM Group’s precision medtech manufacturing platform

RS2 Healthcare Partners invests in KMM Group and appoints J. Mark King as CEO to scale precision medical device manufacturing.

Read More
Dassault Systèmes’ proposed $1.8 billion acquisition of ArisGlobal highlights the growing strategic value of AI-enabled pharmacovigilance, regulatory and life sciences compliance software. Representative image.
Medical Devices & Diagnostics

What the Dassault Systèmes ArisGlobal acquisition means for pharmacovigilance software

Dassault Systèmes is buying ArisGlobal for up to $2bn, betting AI-driven safety and regulatory software can revive life sciences growth.

Read More
Sentante’s CE-marked endovascular robotic platform combines catheter control, force sensing, medical imaging and procedural data capture to build a foundation for future physical AI-assisted vascular interventions. Representative image.
Medical Devices & Diagnostics

What Sentante’s physical AI strategy means for remote endovascular surgery in Europe

Sentante is using its CE-marked endovascular robot to capture force, motion and imaging data, but its clinical AI value still needs proof.

Read More
Orbiva and Articura plan to develop a localized healthcare AI and AIoT ecosystem supporting hospital data integration, remote patient monitoring and digital health services in Indonesia. Representative image.
Medical Devices & Diagnostics

Home Control’s Orbiva signs Indonesia healthcare AI MOU with Articura

Orbiva and Articura plan localized healthcare AI in Indonesia, but validation, data governance and definitive commercial terms remain decisive.

Read More
SimBioSys and Ferrum Health are expanding access to TumorSight Viz, an FDA-cleared AI platform designed to support breast cancer surgical planning using three-dimensional MRI visualisation. Representative image.
Medical Devices & Diagnostics

Can Ferrum Health solve the deployment bottleneck holding back SimBioSys’ TumorSight Viz?

SimBioSys and Ferrum Health bring FDA-cleared TumorSight Viz to Ferrum’s Model Hub, targeting scalable breast surgery AI deployment.

Read More